Acute exacerbation admissions of fibrosing interstitial lung diseases – 3 years study

S. Silva Guerra (Viseu, Portugal), M. Conceição (Viseu, Portugal), Â. Cunha (Viseu, Portugal), J. Correia (Viseu, Portugal), J. Vale (Viseu, Portugal), C. António (Viseu, Portugal), A. Simões Torres (Viseu, Portugal)

Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Session: Assessment and management of immune-mediated interstitial lung diseases
Session type: Thematic Poster
Number: 4739
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Silva Guerra (Viseu, Portugal), M. Conceição (Viseu, Portugal), Â. Cunha (Viseu, Portugal), J. Correia (Viseu, Portugal), J. Vale (Viseu, Portugal), C. António (Viseu, Portugal), A. Simões Torres (Viseu, Portugal). Acute exacerbation admissions of fibrosing interstitial lung diseases – 3 years study. 4739

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Acute exacerbations of interstitial lung diseases:experience of 6 years from a portuguese hospital center
Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2
Year: 2020


Acute exacerbations of progressive-fibrosing interstitial lung diseases
Source: Eur Respir Rev, 27 (150) 180071; 10.1183/16000617.0071-2018
Year: 2018



Clinical course and outcomes of acute exacerbation of fibrosing interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Acute exacerbations of interstitial lung disease
Source: Eur Respir Monogr 2016; 74: 117-131
Year: 2016


Acute exacerbation of interstitial lung diseases as a cause of respiratory failure. Our 3-years experience
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010

Survival after respiratory hospitalization in patients with idiopathic chronic fibrosing interstitial pneumonia
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018




Acute exacerbation of idiopathic pulmonary fibrosis as the initial presentation of the disease
Source: Eur Respir Rev 2009; 18: 129-132
Year: 2009



Management of children with interstitial lung diseases: the difficult issue of acute exacerbations
Source: Eur Respir J 2016; 48: 1559-1563
Year: 2016


Causes of acute exacerbation of chronic obstructive pulmonary disease (COPD) in a hospital in Bucharest
Source: Eur Respir J 2003; 22: Suppl. 45, 240s
Year: 2003

Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature
Source: Eur Respir Rev 2012 21: 355-361
Year: 2012



Clinical experience with nintedanib for the treatment of IPF in 80 cases
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016


Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Pathology of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=159
Year: 2006

Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan
Source: ERJ Open Res, 6 (2) 00184-2019; 10.1183/23120541.00184-2019
Year: 2020



Readmissions after hospitalization for acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010

Recent improvement of survival of acute exacerbation in idiopathic interstitial pneumonias: 10 years experience
Source: International Congress 2014 – ILDs 2
Year: 2014

A proof of concept study by thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Evaluation of incidental exacerbation of interstitial pneumonia in patients with non-respiratory diseases
Source: International Congress 2017 – Rare diseases
Year: 2017

A large cohort study of clinical outcomes and prognostic predictors in patients with acute exacerbation of idiopathic pulmonary fibrosis
Source: International Congress 2014 – IPF and surroundings
Year: 2014

Characteristics and outcomes of hospitalizations for acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012